Relationship Between Heart Failure, Concurrent Chronic Obstructive Pulmonary Disease and Beta-Blocker Use: A Danish Nationwide Cohort Study

Abstract

Carvedilol prescription carried an increased hazard of HF hospitalization and lower restricted mean persistence time among patients with COPD and concurrent HF. Additionally, we found a widespread phenomenon of carvedilol prescription at variance with the European Society of Cardiology guidelines and potential for improving the proportion of patients treated with β-blockers.